[go: up one dir, main page]

AU8743001A - Moraxella polypeptides and corresponding dna fragments and uses thereof - Google Patents

Moraxella polypeptides and corresponding dna fragments and uses thereof

Info

Publication number
AU8743001A
AU8743001A AU8743001A AU8743001A AU8743001A AU 8743001 A AU8743001 A AU 8743001A AU 8743001 A AU8743001 A AU 8743001A AU 8743001 A AU8743001 A AU 8743001A AU 8743001 A AU8743001 A AU 8743001A
Authority
AU
Australia
Prior art keywords
dna fragments
corresponding dna
moraxella polypeptides
moraxella
polypeptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU8743001A
Inventor
Loosmore Sheena
Wang Joe
Bradley Bill
Ochs Martina
Yang Yan-Ping
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Pasteur Ltd
Sanofi Pasteur SA
Original Assignee
Aventis Pasteur Ltd
Aventis Pasteur SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pasteur Ltd, Aventis Pasteur SA filed Critical Aventis Pasteur Ltd
Publication of AU8743001A publication Critical patent/AU8743001A/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • C07K14/212—Moraxellaceae, e.g. Acinetobacter, Moraxella, Oligella, Psychrobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/023—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a poxvirus

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU8743001A 2000-08-28 2001-08-24 Moraxella polypeptides and corresponding dna fragments and uses thereof Pending AU8743001A (en)

Applications Claiming Priority (28)

Application Number Priority Date Filing Date Title
US22829400P 2000-08-28 2000-08-28
US22829600P 2000-08-28 2000-08-28
US22829500P 2000-08-28 2000-08-28
US22843800P 2000-08-29 2000-08-29
US22844300P 2000-08-29 2000-08-29
US22851100P 2000-08-29 2000-08-29
US22877300P 2000-08-29 2000-08-29
US22874200P 2000-08-29 2000-08-29
US22844000P 2000-08-29 2000-08-29
US22844100P 2000-08-29 2000-08-29
US22851200P 2000-08-29 2000-08-29
US22844200P 2000-08-29 2000-08-29
US22843900P 2000-08-29 2000-08-29
US22947800P 2000-09-01 2000-09-01
US22947400P 2000-09-01 2000-09-01
US22946500P 2000-09-01 2000-09-01
US22947500P 2000-09-01 2000-09-01
US22980400P 2000-09-05 2000-09-05
US22980500P 2000-09-05 2000-09-05
US22980900P 2000-09-05 2000-09-05
US22974000P 2000-09-05 2000-09-05
US22981100P 2000-09-05 2000-09-05
US22980600P 2000-09-05 2000-09-05
US22980300P 2000-09-05 2000-09-05
US23021400P 2000-09-06 2000-09-06
US23025200P 2000-09-06 2000-09-06
US23025000P 2000-09-06 2000-09-06
PCT/CA2001/001221 WO2002018595A2 (en) 2000-08-28 2001-08-28 Moraxella polypeptides and corresponding dna fragments and uses thereof

Publications (1)

Publication Number Publication Date
AU8743001A true AU8743001A (en) 2002-03-13

Family

ID=27586817

Family Applications (2)

Application Number Title Priority Date Filing Date
AU8743001A Pending AU8743001A (en) 2000-08-28 2001-08-24 Moraxella polypeptides and corresponding dna fragments and uses thereof
AU2001287430A Abandoned AU2001287430A1 (en) 2000-08-28 2001-08-28 Moraxella polypeptides and corresponding dna fragments and uses thereof

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2001287430A Abandoned AU2001287430A1 (en) 2000-08-28 2001-08-28 Moraxella polypeptides and corresponding dna fragments and uses thereof

Country Status (2)

Country Link
AU (2) AU8743001A (en)
WO (1) WO2002018595A2 (en)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2316563T3 (en) * 2001-05-15 2009-04-16 Id Biomedical Corporation ANTIGENS OF MORAXELLA (BRANHAMELLA) CATARRHALIS.
CA2464957A1 (en) 2001-11-16 2003-05-30 Shire Biochem Inc. Polypeptides of moraxella (branhamella) catarrhalis
EP1768662A2 (en) 2004-06-24 2007-04-04 Novartis Vaccines and Diagnostics, Inc. Small molecule immunopotentiators and assays for their detection
EP1765313A2 (en) 2004-06-24 2007-03-28 Novartis Vaccines and Diagnostics, Inc. Compounds for immunopotentiation
JP2009511636A (en) 2005-10-18 2009-03-19 ノバルティス ヴァクシンズ アンド ダイアグノスティクス， インコーポレイテッド Mucosal and systemic immunity with alphavirus replicon particles
EP2360175B1 (en) 2005-11-22 2014-07-16 Novartis Vaccines and Diagnostics, Inc. Norovirus and Sapovirus virus-like particles (VLPs)
AU2007281934B2 (en) 2006-01-18 2012-11-15 University Of Chicago Compositions and methods related to Staphylococcal bacterium proteins
EP2010537B1 (en) 2006-03-23 2011-12-28 Novartis AG Imidazoquinoxaline compounds as immunomodulators
GB0713880D0 (en) 2007-07-17 2007-08-29 Novartis Ag Conjugate purification
AU2008299376B2 (en) 2007-09-12 2013-02-28 Glaxosmithkline Biologicals S.A. GAS57 mutant antigens and GAS57 antibodies
WO2009081274A2 (en) 2007-12-21 2009-07-02 Novartis Ag Mutant forms of streptolysin o
ES2546213T3 (en) 2008-03-03 2015-09-21 Novartis Ag Compounds and compositions as modulators of TLR activity
AU2010204139A1 (en) 2009-01-12 2011-08-11 Novartis Ag Cna_B domain antigens in vaccines against gram positive bacteria
CN102762226A (en) 2009-06-10 2012-10-31 诺华有限公司 Benzonaphthyridine-containing vaccines
ES2596653T3 (en) 2009-06-16 2017-01-11 Glaxosmithkline Biologicals Sa Opsonization bactericidal and antibody-dependent assays mediated by high-performance complement
TWI445708B (en) 2009-09-02 2014-07-21 Irm Llc Compounds and compositions as regulators of TLR activity
CN102844047B (en) 2009-09-02 2017-04-05 诺华股份有限公司 Immunogenic composition containing TLR active regulators
WO2011057148A1 (en) 2009-11-05 2011-05-12 Irm Llc Compounds and compositions as tlr-7 activity modulators
WO2011084549A1 (en) 2009-12-15 2011-07-14 Novartis Ag Homogeneous suspension of immunopotentiating compounds and uses thereof
EP2549990A1 (en) 2010-03-23 2013-01-30 Irm Llc Compounds (cystein based lipopeptides) and compositions as tlr2 agonists used for treating infections, inflammations, respiratory diseases etc.
CN102933267B (en) 2010-05-28 2015-05-27 泰特里斯在线公司 Interactive hybrid asynchronous computer game infrastructure
US9192661B2 (en) 2010-07-06 2015-11-24 Novartis Ag Delivery of self-replicating RNA using biodegradable polymer particles
GB201102091D0 (en) * 2011-02-08 2011-03-23 Univ Sheffield Antigenic polypeptide
GB201102090D0 (en) * 2011-02-08 2011-03-23 Univ Sheffield Antigenic polypeptide
US9827190B2 (en) 2013-02-01 2017-11-28 Glaxosmithkline Biologicals Sa Intradermal delivery of immunological compositions comprising toll-like receptor 7 agonists
BR112020016314A2 (en) 2018-02-12 2020-12-15 Inimmune Corporation PHARMACEUTICALLY ACCEPTABLE COMPOUNDS OR SALTS, PHARMACEUTICAL COMPOSITION, KIT, AND, METHODS FOR ELICITATING, INTENSIFYING OR MODIFYING AN IMMUNOLOGICAL RESPONSE, TO TREAT, PREVENT OR REDUCE THE SUSCETIBILITY TO CANCER, TO REDUCE, UNDERSTAND TREAT, PREVENT OR REDUCE SUSCEPTIBILITY TO AN ALLERGY, TO TREAT, PREVENT OR REDUCE SUSCETIBILITY TO AUTOIMMUNE AFFECTION, TO TREAT, PREVENT OR REDUCE SUSCETIBILITY IN A SUBJECT TO BACTERIAL INFECTION, ALTERNATE, VENEER, NAVAL, NAVARI TREAT, PREVENT OR REDUCE SUSCEPTIBILITY TO AUTOIMMUNITY, ALLERGY, ISCHEMIA OR SEPSIS REPERFUSION, TO TREAT, PREVENT OR REDUCE THE GRAVITY OF EPILETIC ATTACKS AND TO TREAT, PREVENT OR REDUCE THE MACANTIC HERITAGE OF HERITAGE,
KR20230098825A (en) 2020-11-04 2023-07-04 엘리고 바이오사이언스 Seed. Phage-Derived Particles for In Situ Delivery of DNA Payloads to the Acnes Population

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6335018B1 (en) * 1995-05-01 2002-01-01 Aventis Pasteur Limited High molecular weight major outer membrane protein of moraxella
US6541616B1 (en) * 1998-10-01 2003-04-01 Antex Biologics Inc. Moraxella catarrhalis protein, gene sequence and uses thereof
AU1824101A (en) * 1999-06-18 2001-01-09 Elitra Pharmaceuticals, Inc. Nucleotide sequences of moraxella catarrhalis genome
GB9921691D0 (en) * 1999-09-14 1999-11-17 Smithkline Beecham Sa Novel compounds

Also Published As

Publication number Publication date
AU2001287430A1 (en) 2002-03-13
AU2001287430A8 (en) 2002-03-13
WO2002018595A9 (en) 2007-08-23
WO2002018595A2 (en) 2002-03-07
WO2002018595A3 (en) 2002-10-03

Similar Documents

Publication Publication Date Title
AU8743001A (en) Moraxella polypeptides and corresponding dna fragments and uses thereof
EP1568773A2 (en) Sequence-determined DNA fragments and corresponding polypeptides encoded thereby
AU2001234944A8 (en) Novel nucleic acids and polypeptides
IL206414A0 (en) Novel receptor nucleic acids and polypeptides
AU2001233041A1 (en) Novel nucleic acids and polypeptides
AU2001296235A1 (en) Novel nucleic acids and polypeptides
AU2002246502A1 (en) Nucleic acids and polypeptides
AU2225000A (en) Sequence-determined dna fragments and corresponding polypeptides encoded thereby
IL153568A (en) Novel polypeptides and polynucleotides
AU2001250872A1 (en) Novel nucleic acids and polypeptides
AU2001292561A1 (en) Nucleic acids and polypeptides
IL159872A0 (en) Gmg-2 polypeptides and their use
EP1186615A4 (en) Novel protein and dna thereof
AU2001274566A1 (en) Novel protein and dna thereof
HUP0201660A2 (en) Novel polypeptide and dna thereof
AU2001285155A1 (en) Polymorphic dna fragments and uses thereof
AU7005801A (en) Gp354 nucleic acids and polypeptides
AU2001263005A8 (en) Novel nucleic acids and polypeptides
AU2001294267A1 (en) Survivin-like polypeptides and dnas thereof
AU2001274563A1 (en) Novel polypeptide and its dna
AU7298201A (en) Gp286 nucleic acids and polypeptides
AU2001227925A1 (en) Odorant receptor polypeptides and nucleic acids encoding same
GB0031021D0 (en) Polynucleotides and polypeptides
GB0018307D0 (en) Polypeptides
AU2001269497A1 (en) Novel polypeptide and dna thereof